C-KIT Tyrosine Kinase Protein Overexpression
1 clinical trials · Condition
◉ Watch C-KIT Tyrosine Kinase Protein Overexpression
| Record | Firm | Date |
|---|---|---|
| Ipilimumab and Imatinib Mesylate in Advanced Cancer (NCT01738139) | M.D. Anderson Cancer Center | 2013-02-19 |
Track C-KIT Tyrosine Kinase Protein Overexpression automatically
Every clearance here is in the API, with alerts when new ones post.